Search company, investor...


About AndroScience

AndroScience intends to use its expertise in natural product chemistry to discover compounds that target at different stages of the androgen activation pathway, and to develop lead compounds into new medicines for acne, androgenetic alopecia, wound healing, benign prostatic hyperplasia, prostate cancer and for other androgen or androgen receptor-related disorders.

Headquarters Location

11175 Flintkote Avenue, Suite F

San Diego, California, 92121,

United States

Missing: AndroScience's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: AndroScience's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing AndroScience

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AndroScience is included in 1 Expert Collection, including Cancer.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

AndroScience Patents

AndroScience has filed 10 patents.

patents chart

Application Date

Grant Date


Related Topics




Antiandrogens, Transcription factors, Estranes, Hair loss medications, Human hair


Application Date


Grant Date



Related Topics

Antiandrogens, Transcription factors, Estranes, Hair loss medications, Human hair



Latest AndroScience News

Top Scenario: LIFESTYLE DRUGS Market 2018 | Focusing on Top Key Players like AndroScience, Anterios, AstraZeneca, Avanir Pharmaceuticals, Avolynt, Celtaxsys, Cerecor, Corcept Therapeutics, etc.

Nov 5, 2018

LIFESTYLE DRUGS Market Lifestyle drug is an term commonly applied to medications which treat non-life-threatening and non-painful conditions such as baldness, wrinkles, erectile dysfunction, or acne, which the speaker perceives as either not medical problems at all or as minor medical conditions relative to others. Proponents point out that improving the patient’s subjective quality of life has always been a primary concern of medicine. There is direct impact of lifestyle drugs on society, particularly in the developing world. Implications associated with labeling of indications and products sales of these lifestyle drugs may be varied. Drugs can, over time, switch from ‘lifestyle’ to ‘mainstream’ use. Lifestyle Drugs is also used in adults and children to treat Crohn’s disease or juvenile idiopathic arthritis. Global Lifestyle Drugs Market 2018-2023, has been prepared on the basis of an in-depth market analysis with from industry experts. The report also includes a debate of the leading players working in this market. In order to calculate the  Lifestyle Drugs market  size, the report considers the revenue generated from services provided to end-users such as the pharmaceutical and healthcare companies, medical device manufacturers, contract research organizations, biotechnology companies, and academic and research institutes. Request for Sample report at:   The market research report on the Global Lifestyle Drugs Market by Reports Web is a prominent part of the pharmaceutical and healthcare portfolio and offers insights into the leading trends in the market and potential drivers, including the growth of the Global Lifestyle Drugs Market Industry. The report undergoes a detailed procedure of data collection methodology and presents an in-depth analysis of all the market segments and sub-segments. Any Query or Specific Discount Requirement? Ask our Industry Expert @    Some of the major players operating in the Global Lifestyle Drugs Market include: Allergan, BMS, Eli Lilly, Pfizer, Acerus Pharmaceuticals, Alkermes, Amorepacific, AndroScience, Anterios, AstraZeneca, Avanir Pharmaceuticals, Avolynt, Celtaxsys, Cerecor, Corcept Therapeutics, Cosmo Pharmaceuticals, CTC Bio, Dermira, Dong-A ST, Euthymics Bioscience, Foamix, Follicum, Forendo Pharma, Futura Medical Developments, Galderma, Lifestyle Drugs Market: Product Segment Analysis: Depression, Dermatology, Sexual dysfunction, Obesity, Lifestyle Drugs Market: Application Segment Analysis Children, Adults, Senior Citizens, Competitive Landscape: Global Lifestyle Drugs Market The Global Lifestyle Drugs Market is highly fragmented and is based on new product launches, product advances, and clinical results of products. Therefore, the leading competitors have made use of different strategies, including new product launches, product advances, clinical trials, assumptions and methodologies, high investments on R&D, market initiatives, joint ventures, mergers & acquisitions, agreements, partnerships, and collaborations, to increase their presence in the market. What the report offers: Market Definition, including the product definition and the identification of key drivers and restraints for the market. Market analysis for the Global Lifestyle Drugs Market, with region-specific assessment and competitive landscape on a global and regional basis. Different factors that are instrumental in changing the market situations, emerging growth opportunities, and identification of key companies, which can affect the market on a global and regional scale. Thoroughly researched competitive scenario with the profiles of leading competitors along with their strategic initiatives and market shares. Identification and analysis of the macro and micro factors that affect the Global Lifestyle Drugs Market on both global and regional scale. A complete list of major market participants, including the analysis of their present strategies, investments, and key financial data. Access Full Report Description, TOC and Table of Figure @ The research report studies the market landscape and its growth prospects during the forecast period. Several research tools such as Porter’s five forces analysis, SWOT analysis, and so on. Have been exercised to provide a precise understanding of the overall market. The market research report provides an in-depth analysis of the major trends and technologies that are playing an important role in the growth of the market over the coming years. The study provides a detailed assessment of Global Lifestyle Drugs Market, in terms of revenue, throughout the aforementioned period. About ReportsWeb: is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries. Contact Us:

AndroScience Frequently Asked Questions (FAQ)

  • Where is AndroScience's headquarters?

    AndroScience's headquarters is located at 11175 Flintkote Avenue, Suite F, San Diego.

  • Who are AndroScience's competitors?

    Competitors of AndroScience include Echelon Biosciences, Averica Discovery Services, Terpenoid Therapeutics, EpiTherapeutics, Peakdale Molecular and 13 more.

Compare AndroScience to Competitors

Nereus Pharmaceuticals

Nereus Pharmaceuticals is a drug discovery and development company pursuing sources of chemical diversity through identifying drug candidates derived from marine microbes. With unmatched expertise in marine microbiology and integrated technologies to identify and synthesize biologically active compounds, the company's two oncology drug candidates are in Phase I clinical trials. Plinabulin (NPI-2358), a tumor vascular disrupting agent, is being evaluated for solid tumors, and a proteasome inhibitor NPI-0052 is being developed for solid tumors, lymphomas and multiple myeloma. Nereus' discovery portfolio also includes additional drug candidates for oncology, infectious diseases, and inflammation.

IITRI Drug Discovery Division

IIT Research Institute (IITRI) is a contract research organization (CRO) that aims to provide non-clinical toxicology and other drug development services to government and industry. IITRI offers particular expertise in oncologics drug development, inhalation toxicology and technology, carcinogenesis and cancer prevention, and biodefense. IITRI's Drug Discovery Division is a research-based group whose focus is the design and synthesis of new small molecule therapeutics for cancer and infectious disease.


Syntopix is a specialised research and development business, focusing on the discovery of topical antimicrobials for healthcare and pharmaceutical applications through the repositioning of known chemical entities that have a history of use in humans.nThe company seek to identify compounds and develop products that treat dermatological conditions, principally acne and topical staphylococcal infections, including those due to MRSA.nThe company's antimicrobial expertise is now also being successfully applied to other areas as the company develop collaborative relationships with major healthcare companies.

Terpenoid Therapeutics

Terpenoid Therapeutics is a drug discovery and development company focused on treatments for cancer. The company are developing a portfolio of small molecule- based compounds primarily for treatment of prostate, brease, brain, lung and colon cancers.

Advanced Cancer Therapeutics

Advanced Cancer Therapeutics engages in the discovery, development, manufacture, and commercialization of cancer therapeutics.


VivoPath is a preclinical screening company, offering the company's clients discovery and development services for in vivo testing. VivoPath aims to provide integrated in vivo studies led by established experts in drug development. Efficacy is established for animal models in the areas of metabolic disease, inflammation, neurodegenerative disease, and infectious diseases. Formulation screening is carried out to select the most appropriate delivery system for administration. Pharmacokinetic evaluation is carried out to assess exposure and bioavailability. Tolerability is assessed with evaluations of clinical signs, clinical chemistry and hematology. The resulting program aims to deliver the client an in vivo therapeutic index (TI) report on which to assess candidates for subsequent development. VivoPath can also help clients at any individual step in this preclinical screening process. VivoPath's commitment is to provide scientific expertise in in vivo drug discovery in order to increase productivity from research into drug development.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.